Quest Diagnostics Incorporated (DGX) support and resistance · P/E 22, rev $5.94B
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
This page maps Quest Diagnostics Incorporated (DGX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DGX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DGX quote page for the session range and the stock page for the full model.
Not investment advice.